Midgard Finance drug data
Obesity and incretin drug trials with the estimand on every figure: weight loss by dose and week, adverse events, digitised curves and upcoming readouts.
- Brand
- Midgard Finance
- Category
- Data & Analytics
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
Integration details
Description
Curated data on obesity and incretin drugs from Midgard Finance (midgardfinance.com), with diabetes, antibody-drug conjugates and immunology alongside. Ask for a drug's weight-loss results by dose and timepoint, joined to the trial that produced them; adverse-event rates with the raw counts they were checked against; week-by-week weight-loss curves digitised from the papers; trial designs by NCT number or trial name; and upcoming readouts, approvals and earnings across sponsors. Every efficacy figure carries the estimand it was reported on. The same trial reports different numbers under its treatment-policy and on-treatment (efficacy) analyses, so the server never collapses them into one headline, and a comparison comes with a warning when the estimands differ. Every result links to the midgardfinance.com page it came from, so an answer can cite its source. Read-only and free, with no account or sign-in. It serves only what midgardfinance.com already publishes: no per-drug sales figures and nothing about any person.
- Integration type
- Connector
- Verification status
Community connector- Platform
- Claude
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
- Secondary Subcategories
- None listed
- Brand
- Midgard Finance
- Access
- No account required
- First tracked
- 2026-10-30
- Tool count
- 7
- Market
- US
The Primary Subcategory used for this profile’s headline score.
Other Subcategories where the Integration is listed.
Claude Connector discovery is coming soon
Community Connectors only appear in Claude’s registry.Once verified, organic discovery begins and we can calculate your score.Read more about Community Connector verification.
No spam. Unsubscribe any time.
What discovery looks like

Claude can surface verified Connectors when they match a user’s Prompt.
How Claude Connector discovery works
Your Connector will compete to appear for users’ Prompts once Claude verifies it
Competing in Claude Biomedical & Pharma Research Intelligence
View Category7 tools agents can invoke
Midgard Finance drug data Claude Connector FAQ
How the directory, categories and Discoverability Score work.
Read the methodologyHow do I improve Midgard Finance drug data's Claude Connector discoverability?
The levers are the listing surface agents actually read: names, descriptions, keywords, tool metadata, and registry health. Which lever matters depends on where discovery breaks, which is what continuous measurement shows.
What are Midgard Finance drug data alternatives on Claude?
As of 2026-10-31, Midgard Finance drug data competes with Clinical Trials, AdisInsight, AgingResearch.News, Amass Connector, Boltz API, BPIQ, Convoke, Cortellis CMC Intelligence and 23 more in Claude Biomedical & Pharma Research Intelligence, ranked by public Discoverability Score.
Where is this profile measured?
This profile uses the geography attached to the latest public registry snapshot: US. Locale tags are intentionally omitted.